Article
Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.
Pharmacogenomics - 1 Mar 2011
Lamba Jatinder K, Crews Kristine R, Pounds Stanley B, Cao Xueyuan, Gandhi Varsha, Plunkett William, Razzouk Bassem I, Lamba Vishal, Baker Sharyn D, Raimondi Susana C, Campana Dario, Pui Ching-Hon, Downing James R, Rubnitz Jeffrey E, Ribeiro Raul C
Abstract excerpt
AIM: To identify gene-expression signatures predicting cytarabine response by an integrative analysis of multiple clinical and pharmacological end points in acute myeloid leukemia (AML) patients. MATERIALS & METHODS: We performed an integrated analysis to associate the gene expression of diagnostic bone marrow blasts from acute myeloid leukemia (AML) patients treated in the discovery set (AML97; n = 42) and in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
